Prescription drug · ANDA
Ramipril NDC 51407-709
Ramipril 10 mg/1 · Capsule · Oral · GSMS, Incorporated
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-709-01 | 51407070901 | 100 CAPSULE in 1 BOTTLE (51407-709-01)Marketed from Jul 8, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ramipril
- Generic name (nonproprietary)
- ramipril
- Active ingredients
- Ramipril — 10 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- GSMS, Incorporated
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 079116
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)
- Identifiers
- Product ID 51407-709_9f641c30-6ffa-4765-8991-cc15976b111dSPL ID 9f641c30-6ffa-4765-8991-cc15976b111dSPL set ID 62f6aa5a-7587-4349-b61d-b2c235749979RxCUI 198188, 198189, 261962UNII L35JN3I7SJUPC 0351407708014, 0351407709011
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407070901followed by a unit qualifier and the quantityPackage 51407-0709-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Ramipril Capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. It may be used alone or in combination with thiazide diuretics. ( 1.1 ). In patients 55 years or older at high risk of developing a major cardiovascular event, Ramipril Capsules are indicated to reduce the risk of myocardial infarction, stroke, or death from cardiovascular causes (1.2). Ramipril Capsules indicated in stable patients who have demonstrated clinical signs of congestive heart failure post-myocardial infarction …
Excerpt only. Read the full label for complete information.